Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: Results of a 1-year open-label extension study

Epilepsy Research

Volumn 103, Issue 2-3, 2013, Pages 262-269

  Hufnagel, Andreas ^a   Ben Menachem, Elinor ^b   Gabbai, Alberto A ^c   Falcão, Amílcar ^d,e   Almeida, Luis ^f   Soares da Silva, Patricio ^g,h  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e Health Consulting   (Portugal)

^f UNIVERSITY OF AVEIRO   (Portugal)

^g DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

^h University of Porto   (Portugal)

Author keywords

Antiepileptics; Depressive symptoms; Eslicarbazepine acetate; Long term treatment; Quality of life

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ESLICARBAZEPINE ACETATE; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACKACHE; BLURRED VISION; CLINICAL ASSESSMENT; CONSTIPATION; CONTROLLED STUDY; CONVULSION; COORDINATION; DEPRESSION; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIPLOPIA; DISEASE CONTROL; DISEASE FREE INTERVAL; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; HYPERTENSION; HYPOTENSION; INFLUENZA; INSOMNIA; INTENTION TO TREAT ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; TOOTH PAIN; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; VOMITING; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; DIBENZAZEPINES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873081426     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.07.014     Document Type: Article

References (10)

1. Almeida L., Bialer M., Soares-da-Silva P. Eslicarbazepine acetate. The Treatment of Epilepsy 2009, 485-498. Blackwell Publishing, Oxford. S. horvon, E. Perucca, J. Engel (Eds.).
2. Almeida L., Soares-da-Silva P. Eslicarbazepine acetate (BIA 2-093). Neurotherapeutics 2007, 4:88-96.
3. Ben-Menachem E., Gabbai A.A., Hufnagel A., Maia J., Almeida L., Soares-da-Silva P. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Res. 2010, 89:278-285.
4. Benes J., Parada A., Figueiredo A.A., Alves P.C., Freitas A.P., Learmonth D.A., Cunha R.A., Garrett J., Soares-da-Silva P. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives. J. Med. Chem. 1999, 42:2582-2587.
5. Cramer J.A., Perrine K., Devinsky O., Bryant-Comstock L., Meador K., Hermann B.P. Development and cross-cultural translation of a 31-item quality of life questionnaire (QOLIE-31). Epilepsia 1998, 39:81-88.
6. Elger C., Bialer M., Cramer J.A., Maia J., Almeida L., Soares-da-Silva P. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia 2007, 48:497-504.
7. Elger C., Halasz P., Maia J., Almeida L., Soares-da-Silva P. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia 2009, 50:454-463.
8. Gil-Nagel A., Lopes-Lima J., Almeida L., Maia J., Soares-da-Silva P. Efficacy and safety of 800 and 1200mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol. Scand. 2009, 120:281-287.
9. Halasz P., Cramer J.A., Hodoba D., Czlonkowska A., Guekht A., Maia J., Elger C., Almeida L., Soares-da-Silva P. Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy. Epilepsia 2010, 51:1963-1969.
10. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.